News & Events
decoration

Alex Gadomski Fellowship recipient Dr Kirsten Fairfax leverages funding to expand research into Bone Marrow Failure Syndromes

It has been a great few months for Alex Gadomski Fellowship recipient, Dr Kirsten Fairfax. 

Dr Fairfax has successfully established the capacity to perform single cell sequencing at the University of Tasmania, facilitating projects in Tasmania that would not have previously been possible. Her team has so far been able to generate sequences of RNA from thousands of individual cells from the first seven volunteers who donated bone marrow, with millions more cells from hundreds more samples planned in the coming months to be run on this state-of-the-art platform. 

“Establishing the platform has only been possible due to the funding that Maddie Riewoldt’s Vision has awarded us, and recent funding awarded by the National Health and Medical Research Council,” Dr Fairfax says.

Dr Fairfax has been able to leverage the funding that the Gadomski family has raised in Tasmania to attract nationally competitive government grants, with over a million dollars of government grant funding awarded to the laboratory in the past six months. Dr Fairfax and Prof Hewitt are members of a team of researchers that were recently awarded a grant from the Medical Research Future Fund. This grant is led out of St Vincent’s Institute in Victoria, by Associate Professo Andrew Deans, and has a primary goal of making new gene therapies for bone marrow failure syndromes. The idea is to have both scientists and clinicians involved in the prioritisation and design of the gene therapies. 

By having patients ready who could benefit from any therapeutics that are generated in the course of the research, it will ensure that any technology that is generated can move rapidly and smoothly into the clinic. The team are using a new type of gene editing technology called CRISPR to correct inherited mutations that are found in Bone Marrow Failure Syndrome patients. The research proposed in the grant uses cell lines and mouse models to assess the efficacy and safety of the gene therapies.  

The increase in government grant funding, and the ongoing support from Maddie’s Vision has led to the expansion of the team that is researching into Bone Marrow Failure Syndromes. Prof Hewitt and Dr Fairfax are thrilled at the growth of the team. From just a single researcher dedicated to Bone Marrow Failure Syndromes research in 2019, the team is now recruiting a research assistant, and two additional PhD students, to add to the team which currently includes Ariel Simpson (the Alex Gadomski postgraduate fellow), a new honours student, Caitlin Bidwell (awarded the David Collins Fellowship), and terrific bioinformaticians Thomas Guinan and Dr Kristof Wing. 

Thank you to everyone who has supported the Alex Gadomski Fellowship to make this vital research happen.

Related Articles

Dr Astrid Glaser – inaugural Captain Courageous grant recipient

We are thrilled to announce that Grant Round 1, 2022 Captain Courageous Fellowship has...

Read more

Australian Marrow Failure Biobank Preliminary Application

Maddie Riewoldt’s Vision is delighted to announce the Australian Marrow Failure Biobank (AMFB) Preliminary Application is now open.

Read more

New Saints and Maddie’s Vision merch range to be available soon!

We are excited to announce that we will be launching our brand-new St Kilda FC and Maddie’s Vision merch range at the end of July! Over the last nine years we have collaborated with our ...

Read more

NHMRC Ideas Grant increases funding for Bone Marrow Failure Syndrome research

Dr Vashe Chandrakanthan, Maddie’s Vision Fellow and a member of our Centre of Research Excellence in Bone Marrow Biology, has received an NHMRC Ideas Grant for his project, ...

Read more

Sign up to be the first to hear about our upcoming News & Events